Literature DB >> 26330157

Influenza A virus infection is associated with systemic capillary leak syndrome: case report and systematic review of the literature.

Adrian Sousa1, Oscar Len, Laura Escolà-Vergé, Bruno Magnifico, Chema Mora, Elisabeth Papiol, Eva Revilla, Benito Almirante.   

Abstract

Systemic capillary leak syndrome is a rare and potentially lethal disorder characterized by episodes of vascular hyperpermeability, which lead to shock. Although the pathogenesis is unknown, some viral infections can act as triggers. We present the first case associated with influenza A virus in adulthood, perform a literature review and discuss its treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26330157     DOI: 10.3851/IMP2989

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  5 in total

1.  Choroidal Effusion Mimicking Uveal Melanoma: A Novel Presentation of Idiopathic Systemic Capillary Leak Syndrome.

Authors:  Beatrice Y Brewington; Srinivas Kondapalli; Shaili S Kothari; Samir V Parikh; Colleen M Cebulla
Journal:  Ocul Oncol Pathol       Date:  2021-09-21

2.  Idiopathic Systemic Capillary Leak Syndrome: A Rare Cause of Refractory Shock Following Influenza B Infection.

Authors:  Simon Zec; Hisham A Mushtaq; Anwar Khedr; Abbas Bashir Jama; Ibtisam Rauf; Mikael Mir; Shikha Jain; Thoyaja Koritala; Juan P Domecq Garces; Brian Bartlett; Nitesh K Jain; Syed Anjum Khan
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-07-04

3.  Capillary Leak Syndrome Aggravated by Influenza Type A Infection.

Authors:  James L Lawrence; Hussam Hindi
Journal:  Cureus       Date:  2018-04-30

4.  Severe capillary leak syndrome with cardiac arrest triggered by influenza virus infection.

Authors:  Lotte Ebdrup; Kirk M Druey; Kirk Druey; Trine Hyrup Mogensen
Journal:  BMJ Case Rep       Date:  2018-08-29

5.  Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine.

Authors:  Masatoshi Inoue; Yu Yasue; Yoichi Kobayashi; Yutaka Sugiyama
Journal:  BMJ Case Rep       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.